While elderly patients with heart failure should generally be treated according to current guidelines, management must be tailored to account for comorbidities and avoid untoward effects.
Supports cautious guideline application in elderly HF; leaves open targeted trials on multimorbidity adjustments.
PURPOSE OF REVIEW: Heart failure is a major chronic illness with no definitive cure. With improving healthcare and with an aging population in many countries, heart failure has become a common disease of the elderly. Pharmacological management of heart failure in the elderly remains a challenge. The syndrome of heart failure cannot be isolated from other comorbidities, which are very common in this population. The purpose of this review is to assist practicing clinicians to more effectively make decisions about management of heart failure in the elderly. RECENT FINDINGS: In this review, we will try to integrate recent research studies, recent guidelines, and new treatment modalities, and discuss some controversies. SUMMARY: In general, the elderly patient with heart failure should be treated according to current heart failure guidelines; however, untailored heart failure management may cause untoward effects in this age group and may worsen clinical outcome.
No takes yet. Share an insight, caveat, or question.
Alghamdi et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: